Emerging Pharmaceutical Markets Globally

Report Overview

Table of Contents

875

Select License Type

£875.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,250.00	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£1,000.00	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.
£1,000.00	Disk License Disk License As described. The CD-Rom (where available) is dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£875.00	Add to Wishlist
Change Currency	GBP EURO USD

Market	Healthcare and Medical
Report Type	Market Research
Country	Global
Published	1 November 2011
Number of Pages	120
Report Delivery	Email
Delivery Lead Time	1-3 hours, 24 hour max
Publisher	RNCOS

Report: Contract Research Flourishes in the Pharmaceutical Markets of Emerging Countries

The growth in pharma markets in developing countries with emerging economies (E7 countries) has outpaced the overall growth of the global pharma market. The factors including rapidly growing economies of these countries, increasing per capita income, increasing prevalence of lifestyle diseases, and low-cost are driving the pharma markets in these countries with a fast pace. In 2010, pharma market in E7 countries (Brazil, Russia, China, India, Turkey, Mexico, and Indonesia) was estimated at around US$ 136 Billion, and it is expected to achieve a high growth during 2011-2014, thereby increasing their share in global pharma market.

According to our new research study on the sector titled, ‘Emerging Pharmaceutical Markets Globally', the pharmaceutical market in the abovementioned emerging countries is projected to grow at a double digit CAGR during 2011-2014. Currently, these markets are characterized by rapid urbanization with a change in lifestyle leading to the growth in prevalence of lifestyle diseases.

Our report has found that China has the largest pharma market out of these seven countries, followed by India, Brazil, and Russia. The maximum growth in future is expected to be in China and India due to strong government support and increasing aging population. Besides, we have identified that the prevalence of chronic diseases will remain one of the major drivers for the pharmaceutical market in the E7 counties. Growing pharma industry in emerging countries are also providing immense opportunity for contract research and manufacturing to flourish at rapid pace.

Report Scope

The research study provides extensive and coherent information about pharma markets in the E7 countries. It highlights several emerging opportunities growing in-line with development of pharma markets in E7 countries. The research study provides detailed statistical and analytical review on demographics, macroeconomic indicators, and disease profile. It contains all the key details that will help clients to draw up market strategies and assess opportunity areas for their success in these emerging pharma markets.

Speak to an Advisor

Call us on
+44 (0) 203 086 8600

Select License Type

£875.00	Electronic License Electronic License An electronic version (mostly PDF, but can be Excel or PPT), which is either available for immediate download or will be sent via email by the Publisher of the report. The licencing for an electronic version is for use by the purchaser ONLY.
£1,250.00	Site License Site License An electronic version (mostly PDF, but can be Excel or PPT). Where the report(s) is intended for use by more than one individual, across for example, a site, an office, or a division or country.
£1,000.00	Hard Copy License Hard Copy License As described. Hard copy reports are dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.
£1,000.00	Disk License Disk License As described. The CD-Rom (where available) is dispatched in the post/mail. However, the majority of our reports are in PDF and are either available for immediate download or they are sent by email within hours of purchase.

£875.00	Add to Wishlist
Change Currency	GBP EURO USD

1. Analyst View

2. Research Methodology

3. Global Pharmaceutical Market
3.1 Market Size
3.2 Mature Markets - G7 Countries
3.3 Emerging Markets - E7 Countries
3.4 E7 Countries to Grow Strongly

4. Why E7 Pharmaceutical Market?
4.1 Economic Growth
4.2 Income Level
4.3 Population Base
4.4 Medical & Distribution Infrastructure
4.5 Health Insurance

5. Industry Performance
5.1 Brazil (Past, Present & Future Scenario)
5.1.1 Macroeconomic Indicators
5.1.2 Population Profile
5.1.3 Disease Profile
5.1.4 Healthcare Spending & Financing
5.1.5 Pharmaceutical Market
5.1.6 Import & Export
5.1.7 Branded & Generic Drugs
5.1.8 Key Players
5.2 Russia (Past, Present & Future Scenario)
5.2.1 Macroeconomic Indicators
5.2.2 Population Profile
5.2.3 Disease Profile
5.2.4 Healthcare Spending & Financing
5.2.5 Pharmaceutical Market
5.2.6 Import
5.2.7 Key Players
5.3 India (Past, Present & Future Scenario)
5.3.1 Macroeconomic Indicators
5.3.2 Population Profile
5.3.3 Disease Profile
5.3.4 Healthcare Spending & Financing
5.3.5 Pharmaceutical Market
5.3.6 Import & Export
5.3.7 Branded & Generic Drugs
5.3.8 Key Players
5.4 China (Past, Present & Future Scenario)
5.4.1 Macroeconomic Indicators
5.4.2 Population Profile
5.4.3 Disease Profile
5.4.4 Healthcare Spending & Financing
5.4.5 Pharmaceutical Market
5.4.6 Import & Export
5.4.7 Branded & Generic Drugs
5.4.8 Key Players
5.5 Turkey (Past, Present & Future Scenario)
5.5.1 Macroeconomic Indicators
5.5.2 Population Profile
5.5.3 Disease Profile
5.5.4 Healthcare Spending & Financing
5.5.5 Pharmaceutical Market
5.5.6 Import & Export
5.5.7 Branded & Generic Drugs
5.5.8 Key Players
5.6 Mexico (Past, Present & Future Scenario)
5.6.1 Macroeconomic Indicators
5.6.2 Population Profile
5.6.3 Disease Profile
5.6.4 Healthcare Spending & Financing
5.6.5 Pharmaceutical Market
5.6.6 Import & Export
5.6.7 Branded & Generic Drugs
5.6.8 Key Players
5.7 Indonesia (Past, Present & Future Scenario)
5.7.1 Macroeconomic Indicators
5.7.2 Population Profile
5.7.3 Disease Profile
5.7.4 Healthcare Spending & Financing
5.7.5 Pharmaceutical Market
5.7.6 Import & Export
5.7.7 Branded & Generic Drugs
5.7.8 Key Players

6. Opportunities
6.1 Chronic Diseases
6.2 Pharma Outsourcing Market
6.3 Vaccine Market

7. Restraining Forces
7.1 Counterfeit Drugs
7.2 Patent Protection
7.3 Traditional Medicines

8. Key Players
8.1 GlaxoSmithKline
8.2 Sanofi-Aventis
8.3 Pfizer Inc.
8.4 Novartis
8.5 AstraZeneca

List of Figures

Figure 3-1: Global - Pharmaceutical Market (Billion US$), 2009-2014
Figure 3-2: G7 Countries - Pharmaceutical Market (Billion US$), 2010
Figure 3-3: G7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014
Figure 3-4: G7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014
Figure 3-5: E7 Countries - Pharmaceutical Market (Billion US$), 2010
Figure 3-6: E7 Countries - Forecast for Pharmaceutical Market (Billion US$), 2014
Figure 3-7: E7 Countries - Forecast for Growth of Pharmaceutical Market (%), 2011 to 2014
Figure 3-8: Global - Share of E7 & G7 Countries in Pharmaceutical Market (2010 & 2014)
Figure 4-1: G7 & E7 Countries - Nominal GDP (Trillion US$), 2010 & 2014
Figure 4-2: Global - Share of E7 & G7 Countries Population in Total Population (2010 & 2014)
Figure 4-3: Relative Per Capita Spending on Drugs by Age Group
Figure 5-1: Brazil - Nominal GDP (Billion US$), 2009-2014
Figure 5-2: Brazil - Consumer Price Index (%), 2009-2014
Figure 5-3: Brazil - Foreign Direct Investment (Billion US$), 2009 & 2010
Figure 5-4: Brazil - Population (Million), 2009-2014
Figure 5-5: Brazil - Breakup of Population by Age Group (%), 2009-2014
Figure 5-6: Brazil - Population in the Age Group of 65 Years & Above (Million), 2009-2014
Figure 5-7: Brazil - Breakup of Deaths by Various Causes (%), 2010
Figure 5-8: Brazil - Per Head Healthcare Spending (US$), 2009-2014
Figure 5-9: Brazil - Breakup of Healthcare Payment by Source (%), 2010
Figure 5-10: Brazil - Pharmaceutical Market (Billion US$), 2009-2014
Figure 5-11: Brazil - Pharmaceutical Imports (Billion US$), 2009 & 2010
Figure 5-12: Brazil - Pharmaceutical Exports (Billion US$), 2009 & 2010
Figure 5-13: Brazil - Generic Drugs Market (Billion US$), 2009 & 2010
Figure 5-14: Brazil - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)
Figure 5-15: Russia - Nominal GDP (Billion US$), 2009-2014
Figure 5-16: Russia - Consumer Price Index (%), 2009-2014
Figure 5-17: Russia - Foreign Direct Investment (Billion US$), 2009 & 2010
Figure 5-18: Russia - Population (Million), 2009-2014
Figure 5-19: Russia - Breakup of Population by Age Group (%), 2009-2014
Figure 5-20: Russia - Population in the Age Group of 65 Years & Above (Million), 2009-2014
Figure 5-21: Russia - Breakup of Deaths by Various Causes (%), 2010
Figure 5-22: Russia - Per Head Healthcare Spending (US$), 2009-2014
Figure 5-23: Russia - Breakup of Healthcare Payment by Source (%), 2010
Figure 5-24: Russia - Pharmaceutical Market (Billion US$), 2009-2014
Figure 5-25: Russia - Pharmaceutical Imports (Billion US$), 2009 & 2010
Figure 5-26: India - Nominal GDP (Billion US$), 2009-2014
Figure 5-27: India - Consumer Price Index (%), 2009-2014
Figure 5-28: India - Foreign Direct Investment (Billion US$), FY 2009 & FY 2010
Figure 5-29: India - Foreign Direct Investment in Pharmaceutical Market (Million US$), FY 2009 & FY 2010
Figure 5-30: India - Population (Million), 2009-2014
Figure 5-31: India - Breakup of Population by Age Group (%), 2009-2014
Figure 5-32: India - Population in the Age Group of 65 Years & Above (Million), 2009-2014
Figure 5-33: India - Breakup of Deaths by Various Causes (%), 2010
Figure 5-34: India - Per Head Healthcare Spending (US$), 2009-2014
Figure 5-35: India - Breakup of Healthcare Payment by Source (%), 2010
Figure 5-36: India - Pharmaceutical Market (Billion US$), FY 2009 to FY 2014
Figure 5-37: India - Pharmaceutical Imports (Billion INR), FY 2009 & FY 2010
Figure 5-38: India - Pharmaceutical Exports (Billion INR), FY 2009 & FY 2010
Figure 5-39: India - Breakup of Domestic Pharmaceutical Market by Segment (%), 2010
Figure 5-40: China - Nominal GDP (Billion US$), 2009-2014
Figure 5-41: China - Consumer Price Index (%), 2009-2014
Figure 5-42: China - Foreign Direct Investment (Billion US$), 2009 & 2010
Figure 5-43: China - Population (Million), 2009-2014
Figure 5-44: China - Breakup of Population by Age Group (%), 2009-2014
Figure 5-45: China - Population in the Age Group of 65 Years & Above (Million), 2009-2014
Figure 5-46: China - Breakup of Deaths by Various Causes (%), 2010
Figure 5-47: China - Per Head Healthcare Spending (US$), 2009-2014
Figure 5-48: China - Breakup of Healthcare Payment by Source (%), 2010
Figure 5-49: China - Pharmaceutical Market (Billion US$), 2009-2014
Figure 5-50: China - Pharmaceutical Imports (Billion US$), 2009 & 2010
Figure 5-51: China - Pharmaceutical Exports (Billion US$), 2009 & 2010
Figure 5-52 China - Share of Generic Drugs in Pharmaceutical Market (2010)
Figure 5-53: Turkey - Nominal GDP (Billion US$), 2009-2014
Figure 5-54: Turkey - Consumer Price Index (%), 2009-2014
Figure 5-55: Turkey - Foreign Direct Investment (Billion US$), 2009 & 2010
Figure 5-56: Turkey - Population (Million), 2009-2014
Figure 5-57: Turkey - Breakup of Population by Age Group (%), 2009-2014
Figure 5-58: Turkey - Population in the Age Group of 65 Years & Above (Million), 2009-2014
Figure 5-59: Turkey - Breakup of Deaths by Various Causes (%), 2010
Figure 5-60: Turkey - Per Head Healthcare Spending (US$), 2009-2014
Figure 5-61: Turkey - Breakup of Healthcare Payment by Source (%), 2010
Figure 5-62: Turkey - Pharmaceutical Market (Billion €), 2009-2014
Figure 5-63: Turkey - Share of Imported & Domestically Manufactured Drugs in Pharmaceutical Market (2010)
Figure 5-64: Turkey - Pharmaceutical Exports (Million US$), 2009 & 2010
Figure 5-65: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Value (2010)
Figure 5-66: Turkey - Share of Branded & Generic Drugs in Pharmaceutical Market by Volume (2010)
Figure 5-67: Mexico - Nominal GDP (Billion US$), 2009-2014
Figure 5-68: Mexico - Consumer Price Index (%), 2009-2014
Figure 5-69: Mexico - Foreign Direct Investment (Billion US$), 2009 & 2010
Figure 5-70: Mexico - Population (Million), 2009-2014
Figure 5-71: Mexico - Breakup of Population by Age Group (%), 2009-2014
Figure 5-72: Mexico - Population in the Age Group of 65 Years & Above (Million), 2009-2014
Figure 5-73: Mexico - Breakup of Deaths by Various Causes (%), 2010
Figure 5-74: Mexico - Per Head Healthcare Spending (US$), 2009-2014
Figure 5-75: Mexico - Breakup of Healthcare Payment by Source (%), 2010
Figure 5-76: Mexico - Pharmaceutical Market (Billion US$), 2009-2014
Figure 5-77: Mexico - Pharmaceutical Imports (Million US$), 2009 & 2010
Figure 5-78: Mexico - Pharmaceutical Exports (Million US$), 2009 & 2010
Figure 5-79: Mexico - Share of Branded & Generic Drugs in Pharmaceutical Market (2010)
Figure 5-80: Indonesia - Nominal GDP (Billion US$), 2009-2014
Figure 5-81: Indonesia - Consumer Price Index (%), 2009-2014
Figure 5-82: Indonesia - Foreign Direct Investment (Billion US$), 2009 & 2010
Figure 5-83: Indonesia - Population (Million), 2009-2014
Figure 5-84: Indonesia - Breakup of Population by Age Group (%), 2009-2014
Figure 5-85: Indonesia - Population in the Age Group of 65 Years & Above (Million), 2009-2014
Figure 5-86: Indonesia - Breakup of Deaths by Various Causes (%), 2010
Figure 5-87: Indonesia - Per Head Healthcare Spending (US$), 2009-2014
Figure 5-88: Indonesia - Breakup of Healthcare Payment by Source (%), 2010
Figure 5-89: Indonesia - Pharmaceutical Market (Billion US$), 2009-2014
Figure 5-90: Indonesia - Pharmaceutical Exports (Million US$) 2009 & 2010
Figure 5-91: Indonesia - Pharmaceutical Imports (Million US$) 2009 & 2010
Figure 5-92: Indonesia - Share of Branded & Generic Drugs in Pharmaceutical Market (2008)
Figure 5-93: Indonesia - Share of Top Players in Prescription Pharmaceutical Market, YTD 12 2010
Figure 5-94: Indonesia - Share of Top Players in OTC Pharmaceutical Market (YTD 12 2010)

List of Tables

Table 3-1: Global - Pharmaceutical Market by Region (Billion US$), 2010
Table 4-1: E7 Countries - Disposable Income (Million US$), 2010 & 2014
Table 4-2: G7 Countries - Population (Million), 2010 & 2014
Table 4-3: E7 Countries - Population (Million), 2010 & 2014
Table 4-4: G7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014
Table 4-5: E7 Countries - Population in the Age Group of 65 Years & Above (Million), 2010 & 2014
Table 5-1: Brazil - Share of Top 10 Players in Pharmaceutical Market (2010)
Table 5-2: Russia - Top 10 Pharmaceutical Players by Sales (Million Rubles), 2010
Table 5-3: India - Top 10 Pharmaceutical Players by Sales (Million US$), 2010
Table 6-1: India, China & Brazil - Vaccine Market (Million US$), 2011 & 2013
Table 8-1: GlaxoSmithKline - Strengths & Weaknesses
Table 8-2: Sanofi-Aventis - Strengths & Weaknesses
Table 8-3: Pfizer Inc. - Strengths & Weaknesses
Table 8-4: Novartis - Strengths & Weaknesses
Table 8-5: AstraZeneca - Strengths & Weaknesses

Change Currency

GBP

EURO

USD

Last Viewed

Emerging Pharmaceutical Markets Globally

Mexico Commercial Banking Report Q3 2009

South Africa Agribusiness Report Q2 2010

Express Benchmarking 2009 - United Kingdom

Israel Commercial Banking Report Q3 2009

Healthcare and Medical Company Profiles

Healthcare and Medical Company Profiles contain up to date financial, strategic, operational, SWOT analysis and product information on the activities of thousands of healthcare and medical companies.

Become an Affiliate

Do you manage an industry specific website or blog? Are you looking to monetise your web traffic further? Are you a B2B website?

Why not offer your visitors industry specific strategic market reports and company profiles? Our Affiliate Program enables you to provide quality content on your website and to earn money from passing on visitors to our website. If a sale is made from your visitor, you earn commission (a fixed percentage of the price of a product).

Custom Research

Cannot find what you need? We can tailor a report for you. Complete the Custom Research Form and we will provide a quote.

Healthcare and Medical	Type	Keywords Phrase All Words Any Word
Microsoft Windows users can hold the CTRL Key to select more than one sector or country at a time. Apple users can hold the CMD Key to do the same.	Country	Industry Sector
Publisher	Order By Relevance Date	Published In

Emerging Pharmaceutical Markets Globally

Select License Type

Report: Contract Research Flourishes in the Pharmaceutical Markets of Emerging Countries

Speak to an Advisor

Select License Type

Table of Contents

Change Currency

Last Viewed

Healthcare and Medical Company Profiles

Become an Affiliate

Custom Research

News

Market Insights

Companies And Markets

Customer Support

Corporate Accounts

Contact Details

Contrast settings

Text size settings

All
Afghanistan
Africa
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antigua and Barbuda
Argentina
Armenia
Aruba
Asia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia-Herzegovina
Botswana
Bouvet Island
Brazil
British Virgin Islands
Brunei
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Caribbean
Cayman Islands
Central African Republic
Central America
Central Europe
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Conch Republic
Cook Islands
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Democratic Republic of Congo
Denmark
Djibouti
Dominica
Dominican Republic
Eastern Europe
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Europe
Falkland Islands
Faroe Islands
Fiji
Finland
France
French Guiana
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Global
Greece
Greenland
Grenada
Guadeloupe (French)
Guam (USA)
Guatemala
Guernsey
Guinea
Guinea Bissau
Guyana
Haiti
Heard Island and McDonald Islans
Holy See
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland
Israel
Italy
Ivory Coast
Ivory Coast (Cote D`Ivoire)
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Kurdistan
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macau
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique (French)
Mauritania
Mauritius
Mayotte
Mexico
Micronesia
Middle East
Moldova
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia (French)
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
North America
North Korea
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn Island
Poland
Polynesia (French)
Portugal
Puerto Rico
Qatar
Reunion
Romania
Russia
Rwanda
Saint Barthelemy
Saint Helena
Saint Kitts and Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and Grenadines
Samoa
San Marino
Sao Tome and Principe
Saudi Arabia
Scandinavia
Schengen countries
Senegal
Serbia and Montenegro
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South America
South Georgia and the South Sandwich Islands
South Korea
Spain
Sri Lanka
Sudan
Suriname
Svalbard and Jan Mayen Islands
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Timor-Leste (East Timor)
Togo
Tokelau
Tonga
Trinidad and Tobago
Tunisia
Turkey
Turkmenistan
Turks and Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Vietnam
Virgin Islands
Wallis and Futuna Islands
Western Sahara
Yemen
Zambia
Zimbabwe

All
Aerospace
Agriculture, Farming & Raw Materials
Automotive and Parts
Business Services
Chemicals
Construction
Consumer Goods
Defence
Energy and Utilities
Environmental
Finance and Banking
Food and Drink
Healthcare and Medical
Industrial
Information Technology
Leisure
Logistics
Media
Paper and Packaging
Publishing and Printing
Real Estate
Retail
Security
Telecommunications
Textiles and Clothing
Transportation
Travel